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Abstract
Circulatory shock is a life-threatening disease that accounts for around one-third of all
admissions to intensive care units (ICU). It requires immediate treatment, which is why the
development of tools for planning therapeutic interventions is required to deal with shock in
the critical care environment. In this study, the ShockOmics European project original data-
base is used to extract attributes capable of predicting mortality due to shock in the ICU.
Missing data imputation techniques and machine learning models were used, followed by
feature selection from different data subsets. Selected features were later used to build
Bayesian Networks, revealing causal relationships between features and ICU outcome. The
main result is a subset of predictive features that includes well-known indicators such as the
SOFA and APACHE II scores, but also less commonly considered ones related to cardio-
vascular function assessed through echocardiograpy or shock treatment with pressors.
Importantly, certain selected features are shown to be most predictive at certain time-steps.
This means that, as shock progresses, different attributes could be prioritized. Clinical traits
obtained at 24h. from ICU admission are shown to accurately predict cardiogenic and septic
shock mortality, suggesting that relevant life-saving decisions could be made shortly after
ICU admission.
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Introduction
Shock (or circulatory shock) is a life-threatening medical condition that requires immediate
treatment. It is prevalent in the Intensive Care Unit (ICU) and a major concern in Critical
Care in general. This condition occurs when the organs and tissues of the body do not receive
enough blood and, as a result, cells see their oxygen and nutrients supply restricted so that
organs become damaged. Hypotension, tissue hypoperfusion and hyperlactatemia are amongst
the most common symptoms [1]. The outcome of an individual case depends on the stage of
shock, the underlying condition and the general medical state of the patient [1].
Four types of shock are commonly defined: hypovolaemic shock (e.g. hemorrhagic shock),
cardiogenic shock, distributive shock (e.g. septic shock) and obstructive shock. The mortality
rate of the condition remains very high and depends on its type. It is quantified at 30% for
septic shock (according to the new definition of such condition [2]) and between 35.9% and
64.7% for in-hospital mortality in patients with cardiogenic shock (depending on the stage,
[3]). Usually, shock is treated in the ICU, where it is carefully monitored. As a result, large
amounts of data are produced for each patient.
Machine Learning (ML) techniques can help find a list of attributes to predict the outcome
of shock patients from clinical data (i.e. data routinely monitored in the ICU). However, there
is a large amount of attributes that characterize each patient, ranging from base pathology
information, to lab procedures or hemodynamic data and treatment, to name a few. As a
result, data are likely to be very high dimensional and, therefore, feature selection (FS) meth-
ods are often required to reduce data dimensionality and its associated variability. The combi-
nation of statistics and ML may provide an appropriate framework to retrieve new knowledge
from data, as well as causal relationships between different features from high-dimensional
datasets [4–6].
This study analyzes the clinical database gathered within the ShockOmics research project.
The main objective of this project was to find ‘omics’ signatures of shock and it included two
types of shock: septic and cardiogenic. Septic shock is the most common, and it is caused by
infection. The second most frequent form of shock is the cardiogenic shock and it is a result of
a heart failure. The multiscale nature of the ShockOmics database allows to search for attributes
that are related to mortality induced by these two types of shock.
When it comes to the detection of circulatory shock, physicians and therapists largely
depend on a combination of clinical, hemodynamic and biochemical signs. For a treatment
to be chosen, prompt identification of shock is necessary. Appropriate treatment is based on
a good understanding of the physiological mechanisms behind the condition. The manage-
ment of shock is challenging and patient survival is highly dependent on the timely adminis-
tration of the appropriate treatment. Normally, it requires the administration of vasoactive
drugs and fluid resuscitation. This treatment is usually given to counteract the other condi-
tions that go along with shock (e.g. hypotension/hemodynamic instability, inflammation
and multiple organ failure (MOF)). The fact that they have similar symptoms makes
addressing the causes of shock very difficult. As a result, decision making at the onset of the
condition is not a trivial task and, therefore, it is important to design fast, reliable and inter-
pretable tools to plan therapeutic interventions to prevent mortality, or any irreversible con-
sequences caused by shock.
The study of the pathophysiology of shock and its management has been an active area of
research in ML applications for Critical Care. For example, fuzzy decision support systems
(DDS) for the management of post-surgical cardiac intensive care patients have been described
in [7], while the issue of rule generation for septic shock patients has been addressed in [8] and
[9], the former together with an artificial neural network (ANN). The expert system described
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in [10] is more closely related to the general management of sepsis and it was designed for the
detection of pathogens and the prescription of antibiotics during the first hours of evolution.
Ross and co-workers [11] later derived a system of ordinary differential equations together
with an ANN model of inflammation and septic shock. Other studies have deployed ANNs for
the study of sepsis. They include [12], who presented a clinical study examining SIRS and Mul-
tiple organ dysfunction syndrome (MODS) in the ICU after cardiac and thoracic surgery.
More recently, a state-of-the-art application of a Deep Learning (DL) technique, namely Deep
Reinforcement Learning (DRL) has been proposed by Raghu and co-workers [13] for the defi-
nition of continuous-space models for the treatment of sepsis, in a twist that goes beyond the
more traditional development-and-use of discriminative classifiers. Support vector machine
(SVM) models have also been used for the prediction of sepsis. Kim and co-workers [14]
applied them to study the occurrence of sepsis in post-operative patients. Wang et al. [15]
went a step further to build a DSS for the diagnosis of sepsis.
ML methods have also been used with varying success for the more specific problem of the
prediction of mortality caused by sepsis. A diagnostic system for septic shock based on ANNs
(Radial Basis Functions -RBF- and supervised Growing Neural Gas) was presented in [16].
Also in this area, Brause and colleagues [17] applied an evolutionary algorithm to an RBF net-
work (the MEDAN Project) to obtain, over a retrospective dataset, a set of predictive attributes
for assessing mortality for Abdominal Sepsis. Relevance Vector Machines (RVM), SVM vari-
ants with embedded feature selection, were used in [18], while Bayesian Networks were used
in [19] and [20]. Finally, kernel methods were used in [21].
The work reported in this paper attempts to identify clinical traits that can be used as pre-
dictors of mortality in patients with cardiogenic or septic shock. Missing data imputation tech-
niques and ML models are used, followed by different approaches to FS from different data
subsets. Selected features are later used to build causal Bayesian Networks (CBN), in order to
reveal potential causal relationships between features and ICU outcome.
The remaining of the paper is structured as follows. The section Materials and methods
describes the ShockOmics dataset, as well as the FS, the ML and structure learning methods
used in the reported experiments. The section Experimental Results presents the results for the
FS experiments (obtained feature subsets and their classification performances) and causal dis-
covery experiments (CBN structures). The experimental results are discussed in the section
Discussion. The last section of the paper draws some conclusions about the investigated clini-
cal problem.
Materials and methods
The ML pipeline presented in this paper is divided into two main experimental phases: FS and
causal discovery.
The FS experiments deal with the problem of finding the most promising attributes (clinical
traits) for the prediction of mortality related to shock. To do this, three subsets of the ShockO-
mics data were analyzed: T1, T1+T2 and Full (described below). The goal of the experiments
was to analyze different feature sets resulting from the FS procedure, and to measure their per-
formance using ML models. The decision of starting the analyses with three different data sub-
sets of the ShockOmics database was made due to the importance of obtaining a stable subset
of features that behave consistently at different time-steps and that are clinically relevant. For
this reason, each of the datasets targeted different features: some of them because of their low
amount of missing values, and some of them because they were important at different times.
There is an assumption behind the experiments, namely that the feature sets with the best per-
formances are also the most promising for mortality prediction.
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The evaluated feature sets were obtained by applying four different FS techniques to the
aforementioned datasets: Univariate FS based on ANOVA F-value (UFS); recursive feature
elimination with Support Vector Classification (RFE); two stage FS (UFS+RFE) and Random
Forest (RF) FS. The additional fifth method was applied by averaging stability scores and
aggregating features from the four previous FS techniques results. Missing values were
imputed using RF imputation separately in the training and test sets. The FS techniques were
performed only on the training set. The identification of the promising feature sets was based
on both performance and stability scores.
Finding a subset of attributes that are predictive of mortality due to shock may not suffice
in a clinical setting. The causal discovery experiments reported next allow us to go one step
further and analyze the causal relationships between the data features that were selected in
the previous phase of the ML pipeline. In order to reveal these causal relationships, the Fast
Greedy Search (FGES) algorithm was used. The algorithm was applied twice for each of the
feature subsets obtained in the FS experiments. First, the algorithm was applied only to the fea-
tures, excluding the outcome, and, then, it was applied to both the features and the outcome.
The expectation was to find few or no differences between features that did not involve the
outcome. That would mean that the CBNs are stable enough to draw some clear conclusions.
The CBNs were built using the whole dataset with the selected features imputed by RF.
For the implementation and more detailed information about the methods, please refer to
the corresponding sections.
Dataset description
This study is part of the prospective observational trial ShockOmics European research project
(“Multiscale approach to the identification of molecular biomarkers in acute heart failure
induced by shock”, Nr. 602706—ClinicalTrials.gov Identifier NCT02141607) [22] and was
approved by: the Geneva Regional Research Ethics Committee (study number 14-041), the
Ethical Committee of Hoˆpital Erasme-Universite´ Libre de Bruxelles (study number P2014/
171), and the Mu´tua de Terrassa Hospital Institutional Review Board (study number EO/
1407). The main objective of this project was finding transcriptomics, proteomics and metabo-
lomics signatures of shock as well as finding a robust set of features that could apply to all
shock patients regardless of the initial injury. Patients admitted with both cardiogenic and sep-
tic shock to the intensive care units (ICU) of Geneva University Hospitals, Geneva, Switzerland
(38-bed mixed) and Erasme Univesity Hospital, Brussels, Belgium (36-bed mixed) and Mutua
de Terrassa (12-bed mixed) between October 2014 and March 2016 were screened for inclu-
sion criteria. This study included patients diagnosed with septic or cardiogenic shock who
were older than 18 years with a Sequential Organ Failure Assessment (SOFA) greater than 6,
arterial lactate greater or equal than 2 mmol/l and with a documented source of infection at
admission for patients with septic shock. Patients with a high risk of death within the first 24h
after admission, systemic immunosuppresion, haematological diseases, metastasic cancer, pre-
existing dialysis, decompensated cirrhosis or who had received more than 4 units of red blood
cells or any fresh frozen plasma before screening were excluded from the study [22].
The complete database integrates blood samples and hemodynamic recordings from septic
shock and cardiogenic shock patients, and from septic patients, obtained in the ICU [22]. Clin-
ical data and blood samples were collected for analysis at: 1) T1 < 16 h from T0; 2) T2 = 48 h
after T0; 3) T3 = day 7 or before discharge or before discontinuation of therapy in case of fatal
outcome [23]. Since a lot of patients either died or were discharged during the study, the data-
set has a lot of missing values at later time-steps (especially at T3). A short summary of the clin-
ical data can be found in Table 1.
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The ShockOmics dataset (data are available from the ShockOmics Institutional Data Access
Board for researchers who meet the criteria for access to confidential data) has 333 features
and 75 observations. 32.1% of all values are missing, and the highest percentage of missing val-
ues in one feature is 97%. Fig 1 shows a graphical depiction map of missing values for each
observation. The dataset has both numerical and categorical values, but the majority of the
data is numerical.
The ShockOmics dataset was split into three datasets. The first dataset was named Full and it
was obtained by filtering features from the original ShockOmics dataset. Certain features that
did not make sense from the classification viewpoint were manually removed. They were
either very general comments in natural language or explicitly revealed some information
about the outcome of the patient. Both cases were deemed not to be reliable as features to feed
the ML model. In detail, the following features were manually removed: ID; Reason for admis-
sion; ICU admission; RV area/LV area (T1, T2, T3); Microorganisms (three columns with the
same name); Death due to withdrawal of care; Mortality 28 days, 100 days (two columns); Hos-
pital result; Total days in ICU, in Hospital (two columns). Moreover, the features with more
Table 1. Clinical data summary.
Parameter Cardiogenic shock Septic shock p-values
Number of patients 25 50 -
Gender (Males:Females) 20:5 34:16 -
Outcome (Alive:Dead) 19:6 38:12 -
Body mass index 26.8 ± 5.93 25.22 ± 5.54 0.2591
Total days in ICU 6.6 ± 5.42 7.56 ± 6.54 0.5289
SOFAT1 10.72 ± 4.27 11.50 ± 3.7 0.4165
SOFAT2 8.33 ± 4.92 8.77 ± 4.3 0.699
SOFAT3 5.87 ± 3.68 6.75 ± 4.7 0.5334
APACHE IIT1 24.12 ± 9.79 23.16 ± 7.52 0.6396
APACHE IIT2 18.42 ± 9.41 16.36 ± 8.45 0.3530
APACHE IIT3 12.8 ± 5.35 14.83 ± 5.93 0.2727
Lactate levelsT1 6.04 ± 4.3 4.84 ± 2.58 0.1431
Lactate levelsT2 1.52 ± 0.91 2.1 ± 1.52 0.1126
Lactate levelsT3 1.25 ± 0.5 1.43 ± 0.58 0.3309
Summary of patient populations with cardiogenic and septic shock. Numerical parameters of both populations (mean ± std) are compared against each other with the
Welch’s t-test, where the null hypothesis is that both parameters have identical mean values.
https://doi.org/10.1371/journal.pone.0199089.t001
Fig 1. Graphical depiction map of missing values in ShockOmics dataset. The rows and the columns of the map correspond to observations and
features, respectively. The black color represents missing values, the white color corresponds to present values in the ShockOmics dataset.
https://doi.org/10.1371/journal.pone.0199089.g001
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than 75% of missing data were also removed. The resulting dataset had 286 features with one
target feature.
A research hypothesis is that the closer in time the feature to the final outcome, the better
the prediction of mortality. To test this hypothesis, two further datasets were created, namely
T1+T2 and T1. Both were obtained from the Full dataset by filtering features at certain time-
steps. From the T1+T2 dataset all T3 features were removed, resulting in 206 features with a
target feature. From the T1 dataset both T2 and T3 time-step features were left out, so the
resulting dataset included 114 features and a target feature.
A fourth feature set was built with features that are commonly assumed to be associated
with the mortality of patients with shock, according to current practice. This feature set is
referred to as initial feature set (IFS). Table 2 shows features that were included in the IFS set.
Feature selection and classification
In order to identify promising feature sets, five FS techniques were applied to the first three
data sets described in the previous section. The resulting feature subsets were used to train ML
models and five performance measures were recorded. The first four measures are defined
through the numbers of true positives (TP), true negatives (TN), false positives (FP) and false
negatives (FN):
• Accuracy: TPþTNTPþTNþFPþFN;
• Matthews correlation coefficient (MCC): TP�TN  FP�FNffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðTPþFPÞðTPþFNÞðTNþFPÞðTNþFNÞ
p ;
• Sensitivity: TP
ðTPþFNÞ;
• Specificity: TN
ðTNþFPÞ;
• Area Under the Receiver Operating Characteristic Curve (AUC). The average AUC for
both labels, weighted by the number of true instances for both labels.
Table 2. Initial feature set description.
Name of the feature Observations Type
Which type of shock 75 categorical (4 val)
Lactate levels (mmol/L)T1 72 numerical (cont)
Lactate levels (mmol/L)T2 64 numerical (cont)
Lactate levels (mmol/L)T3 38 numerical (cont)
Mean arterial pressure (mmHg)T1 75 numerical (cont)
Mean arterial pressure (mmHg)T2 71 numerical (cont)
Mean arterial pressure (mmHg)T3 44 numerical (cont)
SOFAT1 75 numerical (cont)
SOFAT2 71 numerical (cont)
SOFAT3 43 numerical (cont)
APACHE IIT1 75 numerical (cont)
APACHE IIT2 71 numerical (cont)
APACHE IIT3 44 numerical (cont)
Result in ICU 75 categorical (2 val)
The columns of the table correspond to the name of the feature, the number of available observations and the type of
the feature. Initial feature set (IFS) consists of 13 features and the target (Result in ICU). Features with missing
observations are highlighted in bold in the Observations column.
https://doi.org/10.1371/journal.pone.0199089.t002
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The experiment pipeline for the FS procedure can be described as follows. First, 100 ran-
dom splits were created for each of the datasets, using 75% for training and the rest for testing.
Then, for each pair of training and test sets RF imputation [24] was used. Both sets were
imputed separately one after another, using an imputed training set for a test set imputation.
After that, the FS methods were applied, varying the size of the desired feature subset from a
minimum of 2 to a maximum of 60. These FS models were subsequently trained on 75% of
data, where only selected features were left in both training and test sets. The feature set that
achieved the highest AUC was chosen as the best one for the split. The same procedure was
applied to the rest of the 99 pairs of training and test sets. Once all feature sets and their perfor-
mance measures were recorded, the mean and the standard deviation were calculated for each
FS method and dataset. The complete experimental pipeline is graphically described in Fig 2.
Now that the best feature sets in all pairs of splits were selected, the stability scores were cal-
culated as frequencies: the individual feature occurrences in all chosen sets were counted and
then divided by the number of pairs (100 in the reported experiments). In the S1 Appendix,
the 80 features with the highest stability scores are listed for each FS technique and dataset, but
note that only the best 20 were later chosen to build CBNs.
The RF data imputation was performed in R (v3.4.3) [25], using missForest package that
allows to impute continuous and/or categorical data including complex interactions and non-
linear relations.
The scikit-learn [26] library (v0.19.1) in Python (v2.7) was used for the implementation of
the FS and ML methods. The default parameters of the methods were used in the experiments,
if not otherwise specified. The five FS techniques used in the identification of promising attri-
butes and the corresponding ML models for feature evaluation are described next:
• Univariate feature selection based on ANOVA F-values (UFS). Univariate feature selection
[27] works by selecting the best features based on univariate statistical tests. In this case,
ANOVA F-tests are used. The Gaussian Naive Bayes model [28] was used for the evaluation.
The UFS was implemented using the sklearn.feature_selection.SelectKBest method that
removes all but the k highest scoring features and sklearn.feature_selection.f_classif for the
ANOVA F-tests. The Naive Bayes model was implemented through the sklearn.naive_bayes.
GaussianNB method.
Fig 2. Graphical representation of the experimental pipeline. The process of FS and classification consists of the following steps: 1) create 100
random splits of the dataset: 75% for training and 25% for testing; 2) for each split impute both sets separately, using the imputed training set for a test
set imputation; 3) after that, use the FS technique on the imputed training set, varying the size of the selected feature set (from a minimum of 2 to a
maximum of 60), then choose the selected features in both sets, creating new pairs of training and test sets; 4) finally, using sets with different amounts
of features, train and evaluate a ML model and choose the one with the highest AUC; record which and how many features were used for training this
model, and its performance measures. Repeat these steps for all 100 random splits for each dataset and FS technique.
https://doi.org/10.1371/journal.pone.0199089.g002
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• Recursive feature elimination with SVC (RFE). Given an external estimator that assigns
weights to features (e.g., the coefficients of a linear model), the goal of the RFE is to select
features by recursively considering smaller and smaller sets of features [29]. The RFE was
implemented through the sklearn.feature_selection.RFE method. For the external estimator
and, as the evaluated ML model, the SVC [30] was used with the help of the sklearn.svm.
SVC method;
• Two stage FS (UFS + RFE). A combination of two FS techniques from this list. In the first
stage, UFS preselects the 120 best features (80 for the T1 dataset) based on the ANOVA F-
value and then RFE (SVC) chooses the best features in the second stage. Here, the SVC was
used as the ML model for the evaluation;
• Random Forest (RF) FS. This method [29] is based on the trained RF model [31] and its fea-
ture rankings. The sklearn.feature_selection.SelectFromModel method was used to retrieve
the feature rankings and the sklearn.ensemble.RandomForestClassifier method to train the
RF model for the FS and later (with only selected features) for evaluation (10 trees were used
in each stage);
• Aggregated (Aggr.) FS. The method uses the averaged stability scores for FS obtained by the
four previous techniques and, therefore, does not include the ML model. Instead, the perfor-
mance is measured by averaging the measures obtained by the previous methods. This FS
does not involve any processing of the dataset, but relies heavily on the previous FS tech-
niques. As a result, it allows to achieve more stable features and analyze the aggregated per-
formance of all trained ML models for the dataset.
Structure learning
The FGES algorithm was used to obtain the CBN structures that would reveal the interactions
between the features. This is an optimized and parallelized version of the Greedy Equivalence
Search algorithm. It heuristically searches the space of CBNs and returns the model with the
highest value for the Bayesian Information Criterion (BIC) [32] it finds. It starts with an empty
graph and adds new edges to increase the Bayesian score. The process stops when there are no
edges that increase the score. It then starts removing edges until no single edge removal can
increase the score.
The algorithm works on the assumption that the causal process generating the data is accu-
rately modeled by a CBN. Each node in this CBN is a a linear function of its parents, plus a
finite additive Gaussian noise term. Each observation in the data is assumed to be independent
and obtained by randomly sampling all the variables from the joint distribution. Given all
these assumptions, the FGES procedure outputs the CBN structure that contains:
1. an arc X! Y, if and only if X causes Y;
2. an edge (-), if and only if either X causes Y or Y causes X;
3. no edge between X and Y, if and only if X and Y have no direct causal relationship between
them.
The Tetrad software (v6.4.0) was used in the implementation of FGES. The algorithm was
applied twice for each of the feature sets obtained during the feature selection phase. First, the
algorithm was applied only to the features, excluding the outcome, while the second time it
was instead applied to both features and the outcome. The expectation was to have few or no
differences between features that did not involve the outcome. That would mean that the
Feature selection for shock mortality prediction
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CBNs are stable enough to draw clear conclusions. The algorithm used the default parameters
and seven maximum discrete categories.
Experimental results
Feature selection experiments
The FS experiments are divided into three groups. Each group corresponds to its own dataset:
Full, T1+T2 and T1. All five FS techniques were applied to each dataset. The results were used
to train the ML model, and the performance of each feature set was evaluated for each model.
In this section, the best models from all FS experiments and their accuracy, MCC, sensitivity,
specificity and AUC are presented. For the details on individual features and their stability
scores please refer to the S1 Appendix. Considering the 80 features with the highest stability
scores for each FS technique and dataset, one may appreciate how the selected features vary
across the 100 random splits.
Table 3 shows the comparison of different FS techniques and the general performance of
the best features they chose: the size of the feature set, the dataset and the FS method used. The
FS techniques that were applied to the same dataset are grouped together. The additional IFS
dataset is used as a baseline to compare the rest of feature sets performances (the Gaussian
Naive Bayes was chosen as the ML model). A naive majority classifier that always predicts the
most frequent label in the training set, was also added for baseline comparison.
As it can be seen from Table 3, the FS models outperform manually chosen features from
the IFS. Moreover, the IFS model is only slightly better than the naive majority classifier. The
data is unbalanced and that is the reason why the accuracy and the specificity are the only mea-
sures for which the majority classifier is better. As for the rest of the models, they show consis-
tently better results than the baseline. The only exception is the specificity measure, which
means that there were no models that identified all negative examples correctly across all 100
random splits, and the accuracy for the RFE and UFS+RFE techniques with the Full dataset.
The RF models produced consistently good results in all datasets, and were considered best for
every dataset. The best result of all experiments were shown by one of these models for the T1
+T2 dataset. Based on the Aggr. performance, the general performance of the models declined
with the additional time-steps. This can be explained by the lower performance of the RFE and
UFS+RFE models for the T1+T2 dataset, compared to the T1, and by the fact that the Full
models performed the worst across all three datasets.
For the causal discovery experiments, it was decided to choose the 20 features with the high-
est stability scores for the models whose results are shown in Table 4. The RF models showed
the best performance and therefore their features required more thorough investigation. All
feature sets selected for the causal discovery experiments and their individual features can be
found in Box 1 below.
Within square brackets: the subset of data that was used to obtain the feature set and the
applied FS technique.
Causal discovery
For each of the feature sets there are two corresponding CBNs. The first one (the CBN ‘a’ was
built without the target feature (Result in ICU), the second one (the CBN ‘b’) included all fea-
tures and the target. This section contains the CBNs and their descriptions for the (T1, RF)
and (T1+T2, RF) feature sets. For the rest of CBNs, please refer to the S1 Appendix.
Fig 3 shows the CBNs for the (T1, RF) feature set. As it can be seen, two nodes, namely E
wave and E/e at T1 are detached from the rest of the network in both CBNs. In CBN ‘a’, all
edges are undirected, but the addition of the target feature, Result in ICU, changes most of
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them to directed. Moreover, adding this feature replaces the edge between Lactate levels and
Norepinephrine at T1 to the edge between K Ur and Na Ur at T1, connecting these two nodes
to the CBN. According to the CBN ‘b’, Result in ICU can be potentially influenced by Norepi-
nephrine, Respiratory rate, Platelet count and SOFA at T1.
Fig 4 shows the CBNs for the (T1+T2, RF) feature set. In both CBNs, no edges are con-
nected to K Ur at T1. This time, the addtion of the outcome attaches E wave at T1 and Neutro
abs count at T2 to the rest of the network. There are multiple changes across the CBN that
involve other features as well. For example, edges between Glasgow Coma Scale at T1 and Lac-
tate levels at T2, and between Lactate levels at T2 and PT at T2 disappear. Moreover, for all
edges the causal directions become clear, and new edges emerge. The CBN ‘b’ shows that
Table 3. The performance comparison of the feature sets.
# Features Data Method Accuracy MCC Sensitivity Specificity AUC
- - Majority class 0.763 ± 0.09
(0.0)
0.0 ± 0.0
(0.0)
0.0 ± 0.0
(0.0)
1.0 ± 0.0
(0.0)
0.5 ± 0.0
(0.0)
11 IFS - 0.644 ± 0.124
(0.0)
0.028 ± 0.255
(0.0)
0.269 ± 0.252
(0.0)
0.767 ± 0.14
(0.0)
0.518 ± 0.139
(0.0)
13.5 ± 13.6 T1 UFS 0.828 ± 0.083
(0.0)
0.573 ± 0.183
(0.0)
0.731 ± 0.217
(0.2496)
0.873 ± 0.095
(0.0)
0.802 ± 0.108
(0.0037)
16.5 ± 13.2 T1 RFE 0.823 ± 0.079
(0.0)
0.549 ± 0.19
(0.0)
0.702 ± 0.23
(0.0396)
0.876 ± 0.089
(0.0001)
0.789 ± 0.114
(0.0003)
14.5 ± 13.0 T1 UFS+RFE 0.814 ± 0.077
(0.0)
0.52 ± 0.181
(0.0)
0.656 ± 0.226
(0.0004)
0.876 ± 0.092
(0.0001)
0.766 ± 0.106
(0.0)
18.1 ± 10.8 T1 RF 0.87 ± 0.07
(0.4397)
0.668 ± 0.152
(0.268)
0.755 ± 0.198
(0.7221)
0.922 ± 0.074
(0.7848)
0.839 ± 0.092
(0.6576)
15.7 ± 12.8 T1 Aggr. 0.834 ± 0.08
(0.0001)
0.577 ± 0.186
(0.0)
0.711 ± 0.221
(0.0709)
0.887 ± 0.09
(0.002)
0.799 ± 0.109
(0.0021)
10.8 ± 14.2 T1+T2 UFS 0.839 ± 0.085
(0.0008)
0.584 ± 0.207
(0.0001)
0.715 ± 0.229
(0.101)
0.889 ± 0.091
(0.0035)
0.802 ± 0.116
(0.0053)
17.5 ± 15.8 T1+T2 RFE 0.807 ± 0.089
(0.0)
0.503 ± 0.205
(0.0)
0.637 ± 0.265
(0.0002)
0.874 ± 0.101
(0.0001)
0.755 ± 0.122
(0.0)
12.9 ± 10.7 T1+T2 UFS+RFE 0.796 ± 0.074
(0.0)
0.465 ± 0.175
(0.0)
0.596 ± 0.251
(0.0)
0.873 ± 0.097
(0.0001)
0.734 ± 0.109
(0.0)
21.2 ± 14.4 T1+T2 RF 0.878 ± 0.076
(1.0)
0.693 ± 0.166
(1.0)
0.765 ± 0.199
(1.0)
0.925 ± 0.081
(1.0)
0.845 ± 0.099
(1.0)
15.6 ± 13.9 T1+T2 Aggr. 0.83 ± 0.087
(0.0)
0.561 ± 0.208
(0.0)
0.678 ± 0.246
(0.0065)
0.89 ± 0.095
(0.0056)
0.784 ± 0.12
(0.0001)
17.9 ± 17.2 Full UFS 0.754 ± 0.105
(0.0)
0.31 ± 0.23
(0.0)
0.431 ± 0.256
(0.0)
0.861 ± 0.129
(0.0)
0.646 ± 0.119
(0.0)
19.7 ± 16.5 Full RFE 0.758 ± 0.088
(0.0)
0.334 ± 0.213
(0.0)
0.483 ± 0.278
(0.0)
0.855 ± 0.114
(0.0)
0.669 ± 0.118
(0.0)
17.4 ± 15.2 Full UFS+RFE 0.743 ± 0.09
(0.0)
0.311 ± 0.21
(0.0)
0.477 ± 0.251
(0.0)
0.839 ± 0.123
(0.0)
0.658 ± 0.111
(0.0)
21.9 ± 15.5 Full RF 0.819 ± 0.082
(0.0)
0.53 ± 0.176
(0.0)
0.614 ± 0.244
(0.0)
0.902 ± 0.087
(0.0544)
0.758 ± 0.111
(0.0)
19.2 ± 16.2 Full Aggr. 0.769 ± 0.096
(0.0)
0.371 ± 0.228
(0.0)
0.501 ± 0.267
(0.0)
0.864 ± 0.117
(0.0)
0.683 ± 0.123
(0.0)
Best feature sets obtained in the FS experiments and their general performance across 100 random data splits. The columns correspond to the number of features, the
data that were used to obtain the feature set, the FS method and five performance measures (mean ± std(p − value)). Welch’s t-test was used to obtain p-values for the
null hypothesis that two performance measures had identical values. Each measure was tested against the same measures of the (T1+T2, RF)) model. The IFS dataset was
used as a baseline for comparison. The best results for all measures in each dataset group are highlighted in bold.
https://doi.org/10.1371/journal.pone.0199089.t003
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Result in ICU is potentially influenced by E wave at T1, Norepinephrine at T2, Neutro abs count
at T2 and SOFA at T2.
In most of CBNs pairs, the presence of the target value did not imply much change. The
majority of edges of the Full models were undirected and the parts of the network were
detached from each other. Adding Result in ICU does not connect these separate parts. This
contrasts with the T1 and T1+T2 models, that have more or less connected CBNs. As for the
T1 and T1+T2 CBNs, they have common patterns that are noticeable throughout the experi-
ments. More importantly, the two best models described in this section have some common
features that are close to the outcome in both CBNs. These similarities are discussed in the
next section.
Discussion
Analyzing the results of the FS experiments, one may notice that there are a lot of reoccurring
features with high stability scores for each of the datasets. These features can be clearly seen
from the Aggr. tables in page 19. For T1 the most common features are APACHE II, SOFA,
respiratory rate, Glasgow coma scale and K Ur. All these features except Glasgow coma scale
scored high with the model that showed the best results for this dataset. Moreover, some of
them were also present in the results for T1+T2. Interestingly, there are many similar features
that scored high in both T1 and T1+T2, which is a clear indication of their importance for the
mortality prediction task.
Regarding the T1+T2 dataset, the most stable features are APACHE II at T1, SOFA at T2,
tricuspid regurgitation maximal velocity at T1, Glasgow Coma Scale at T1 and neutrophils abso-
lute count at T2. It is especially interesting that some attributes at T1 occurred more frequently
than their T2 counterparts. This can be explained by the fact that features at later time-steps
present more noise and missing features. However, the (T1+T2, RF) showed the best predictive
power in our experiments, which means that at least some T2 features improved the results
obtained.
In contrast, the worst performance was that obtained for the Full dataset. Its most stable fea-
tures include A wave at T2, systolic blood pressure at T2, heart rate at T1, respiratory rate at T1
and weight. These features scored the highest, but their stability scores are very low. Moreover,
Table 4. The performance of the feature sets selected for the causal discovery experiments.
# Features Data Method Accuracy MCC Sensitivity Specificity AUC
18.1 ± 10.8 T1 RF 0.87 ± 0.07
(0.4397)
0.668 ± 0.152
(0.268)
0.755 ± 0.198
(0.7221)
0.922 ± 0.074
(0.7848)
0.839 ± 0.092
(0.6576)
15.7 ± 12.8 T1 Aggr. 0.834 ± 0.08
(0.0001)
0.577 ± 0.186
(0.0)
0.711 ± 0.221
(0.0709)
0.887 ± 0.09
(0.002)
0.799 ± 0.109
(0.0021)
21.2 ± 14.4 T1+T2 RF 0.878 ± 0.076
(1.0)
0.693 ± 0.166
(1.0)
0.765 ± 0.199
(1.0)
0.925 ± 0.081
(1.0)
0.845 ± 0.099
(1.0)
15.6 ± 13.9 T1+T2 Aggr. 0.83 ± 0.087
(0.0)
0.561 ± 0.208
(0.0)
0.678 ± 0.246
(0.0065)
0.89 ± 0.095
(0.0056)
0.784 ± 0.12
(0.0001)
21.9 ± 15.5 Full RF 0.819 ± 0.082
(0.0)
0.53 ± 0.176
(0.0)
0.614 ± 0.244
(0.0)
0.902 ± 0.087
(0.0544)
0.758 ± 0.111
(0.0)
19.2 ± 16.2 Full Aggr. 0.769 ± 0.096
(0.0)
0.371 ± 0.228
(0.0)
0.501 ± 0.267
(0.0)
0.864 ± 0.117
(0.0)
0.683 ± 0.123
(0.0)
The columns of the table correspond to the number of features, the data that was used to obtain the feature set, the FS method used and five performance measures
(mean ± std(p value)). Each measure was tested against the same measures of the (T1+T2, RF) model. The best results in the performance measures columns are
highlighted in bold.
https://doi.org/10.1371/journal.pone.0199089.t004
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the difference between all scores of the Full dataset is very small. This means that during the FS
procedures across 100 random experiments, very different features were selected making them
unreliable for their low stability. This supports the hypothesis that adding more time-steps
(i.e., later times) increases noise, and that the current amount of data is not sufficient enough
to bypass this problem.
The performance of features from different datasets and models were further compared to
the model that showed the best results, which was the (T1+T2, RF) model. More specifically,
the performance measures of (T1+T2, RF) were tested against the measures of other models,
Box 1. List of best feature selections
[T1, RF]: APACHE II T1, SOFA T1, Respiratory rate T1, Urine Output (mL/day) T1, E
wave (cm/s) T1, Fluid Balance (ml) T1, K Ur T1, Lactate levels (mmol/L) T1, Tidal vol-
ume (VT) T1, Pulmonary artery systolic pressure (TR jet by CW + CVP) (mmHg) T1, �
Norepinephrine (mg/kg/min) T1, PCT Value (mg/mL) T1, Heart rate (bpm) T1, E/e’
T1, PEEP T1, Pplat T1, Platelet count T1, Na Ur T1, pH T1, PaO2/FiO2 T1;
[T1, Aggr.]: APACHE II T1, SOFA T1, Respiratory rate T1, Glasgow Coma Scale T1, K
Ur T1, Platelet count T1, Tidal volume (VT) T1, Tricuspid regurgitation maximal veloc-
ity (by CW) (cm/s) T1, HCO3 (mmol/L) T1, LA dilatation by eyeballing T1, Pulmonary
artery systolic pressure (TR jet by CW + CVP) (mmHg) T1, Base Excess (mmol/L) T1, E
wave (cm/s) T1, PCT Value (mg/mL) T1, Respiratory rate (rpm) T1, Pplat T1, Tricuspid
annular tissular doppler S wave (DTI) (cm/s) T1, � Norepinephrine (mg/kg/min) T1, �
Dobutamine (mg/kg/min) T1, Lactate levels (mmol/L) T1;
[T1+T2, RF]: Lactate levels (mmol/L) T2, SOFA T2, Tidal volume (VT) T2, APACHE II
T1, Urine Output (mL/day) T1, Urine Output (mL/day) T2, APACHE II T2, Respiratory
rate T1, K Ur T2, SOFA T1, � Norepinephrine (mg/kg/min) T2, Neutro abs count T2, E
wave (cm/s) T1, Na Ur T2, pH T2, K Ur T1, Glasgow Coma Scale T2, Tricuspid regurgi-
tation maximal velocity (by CW) (cm/s) T1, PT T2, Pulmonary artery systolic pressure
(TR jet by CW + CVP) (mmHg) T1;
[T1+T2, Aggr]: APACHE II T1, SOFA T2, Tricuspid regurgitation maximal velocity (by
CW) (cm/s) T1, Glasgow Coma Scale T1, Neutro abs count T2, Glasgow Coma Scale T2,
Platelet count T1, K Ur T1, APACHE II T2, SOFA T1, Respiratory rate T1, HCO3
(mmol/L) T1, Lactate levels (mmol/L) T2, E wave (cm/s) T1, Tidal volume (VT) T1,
Respiratory rate (rpm) T1, K Ur T2, Na Ur T2, PT T2, LA dilatation by eyeballing T1;
[Full, RF]: Neutro abs count T1, Platelets (10 3/mm 3) T3, E/e’ T2, Lateral e’ (cm/s) T2,
Creat Ur T2, Urine Output (mL/day) T2, Lateral e’ (cm/s) T1, Respiratory rate (rpm)
T1, Lympho abs count T1, Mean arterial pressure (mmHg) T1, Diastolic Blood Pressure
(mmHg) T2, E wave deceleration time (ms) T2, Tricuspid annular tissular doppler S
wave (DTI) (cm/s) T1, Sat O2/FiO2 T2, Platelets (10 3/mm 3) T1, FiO2 T3, Tidal volume
(VT) T1, RBC count T3, Fluid Balance (ml) T2, Platelet count T2;
[Full, Aggr]: A wave (cm/s) T2, Systolic blood pressure (mmHg) T2, Heart rate (bpm)
T1, Respiratory rate (rpm) T1, Weight (kg), Height (cm), A wave (cm/s) T1, PT T1, E
wave deceleration time (ms) T3, Hematocrit (%) T2, Platelet count T3, Creat Ur T1, E
wave deceleration time (ms) T1, PaCO2 (mmHg) T1, K Ur T1, E wave (cm/s) T2, aPTT
T1, Mean arterial pressure (mmHg) T1, Base Excess (mmol/L) T1, PaO2 (mmHg) T2.
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using the Welch’s t-test. The null hypothesis was that each pair of performance measures has
identical values. Setting the threshold for the p-value to 0.05 shows that there is a significant
chance that the (T1, RF) and (T1+T2, RF) models perform similarly according to all five per-
formance measures. For this reason, these models were singled out in the causal discovery
experiments.
The CBN structures revealed connections between the features and the outcome. The
assumption behind the evaluation of the most important clinical attributes for outcome pre-
diction was that such features are the closest to the outcome in a graph. The direction of the
edge from feature to the outcome is also a good indicator that a certain feature is important.
According to the RF and Aggr. CBNs for the T1 dataset, Result in ICU is influenced by nor-
epinephrine and SOFA at T1. Both models presented direct connections between these two
features and the outcome. The additional possible candidates, supported by the (T1, RF), are
respiratory rate and platelet count at T1. E wave, dobutamine and tricuspod regurgitation maxi-
mal velocity at T1 were considered important by the (T1, Aggr.) pair. As for the T1+T2 dataset,
its RF and Aggr. models show the significance of neutrophils absolute count at T2. Additional
features that are directly connected to Result in ICU in the RF CBN include norepinephrine at
T2, E wave at T1 and SOFA at T2. The Aggr. model adds APACHE II at T2 to the list. The Full
CBNs show that the selected features do not create any coherent structure and, hence, cannot
be used to draw any conclusions. This can be explained by the low stability scores and the lack
of variability among them in the previous experiments.
Some parallels can be seen between the features that achieved high Aggr. stability scores and
those that were considered important in the causal discovery experiments. These features were
ranked very high by the FS techniques and had the direct connection to the outcome. These
features include SOFA at T1, respiratory rate at T1, tricuspid regurgitation maximal velocity at
Fig 3. The (T1, RF) CBN. The CBN for the (T1, RF) feature set, obtained: a) without the target feature; b) with the target feature.
https://doi.org/10.1371/journal.pone.0199089.g003
Fig 4. The (T1+T2, RF) CBN. The CBN for the (T1+T2, RF) feature set obtained: a) without the target feature; b) with the target feature.
https://doi.org/10.1371/journal.pone.0199089.g004
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T1, neutrophils absolute count at T2 and SOFA at T2. Additional features that were in the top
20 of the Aggr. stability scores tables but were ranked lower are norepinephrine at T1, platelet
count at T1, E wave at T1 and dobutamine at T1. The full list of features that were considered
valuable for the mortality prediction task can be found in Box 2. Since the Full features had
very low stability scores, only the first few T1 and T1+T2 features from Aggr. tables were con-
sidered important.
List of attributes that were considered promising for the outcome prediction in patients
with shock.
These findings agree with other studies that support the use of certain attributes for mortal-
ity prediction. For instance, the SOFA score has previously been shown to have a significant
prognostic value for in-hospital mortality prediction [33] [34]. The APACHE II score is often
used for outcome prediction too [35–37]. And in the study by Jansen et al. [38], targeting a
decrease of at least 20% in the blood lactate level (a common feature for the best two models)
over a 2-hour period seemed to be associated with reduced in-hospital mortality in patients
with shock. However, some of the attributes that are also related to mortality in patients with
shock, like mean blood pressure [39], mean arterial pressure [40], or low LVEF [41] did not
show significant predictive value in this study.
Finally, it should be noted that some features seem more important at certain time-steps.
For example, the difference in stability scores shows that neutrophils absolute count at T2, tri-
cuspid regurgitation maximal velocity at T1 and dobutamine at T2 were selected far more often
than their counterparts. This might be due to the specifics of imputation or due to the lack of
data. In any case, this hypothesis requires a more thorough investigation, that is beyond the
scope of this work.
Conclusion
In this paper, we have analyzed and experimentally compared several models for the predic-
tion of mortality in patients with cardiogenic or septic shock, identifying those clinical traits
that are more relevant for such prediction in the ICU at different time-points. These models
are the result of the application of different FS techniques over the available clinical data. In
particular, we were interested in obtaining an actionable classifier for the acute phase of shock,
which is the most critical to implement an appropriate therapeutic response and, therefore,
has the greater impact on the prognosis of patients. For the acute phase (i.e. the first 24 hours
of evolution of shock), we have obtained a classifier that leverages upon well established attri-
butes for septic shock such as the SOFA or APACHE II scores and treatment with vasopressors
(for example, norepinephrine), which are part of the cardiovascular SOFA score. This classifier
for the acute phase of shock also resorts to other valuable attributes such as those obtained
Box 2. List of promising attributes
High stability scores features: APACHE II T1, SOFA T1, Respiratory rate T1, Glasgow
Coma Scale T1, K Ur T1, SOFA T2, Tricuspid regurgitation maximal velocity T1, Neutro
abs count T2, Glasgow Coma Scale T2.
Causal discovery features: Norepinephrine T1, SOFA T1, Respiratory rate T1, Platelet
count T1, E wave at T1, Dobutamine T1, Tricuspod regurgitation maximal velocity T1,
Neutro abs count T2, Norepinephrine T2, SOFA T2, APACHE II T2.
Feature selection for shock mortality prediction
PLOS ONE | https://doi.org/10.1371/journal.pone.0199089 November 20, 2018 14 / 18
through echocardiography during cardiogenic shock (e.g. E wave velocity, early mitral inflow
velocity and mitral annular early diastolic velocity (E/e’)). Other important attributes are
related to respiratory function (such as respiratory rate, tidal volume and ventilator pressures),
fluid balance, pulmonary artery pressure, renal function (such as urine output and urea levels),
lactate levels, acidosis and C-reactive protein levels. These significant attributes are very closely
related to the new official definition of shock and its corresponding management guidelines,
in particular those related to organ dysfunction and respiratory function. However, our causal
discovery experiments showed that treatment with pressors, respiratory rate, platelet count
and the SOFA score presented the highest dependence with ICU outcome. The best classifier
for the acute phase yielded an accuracy of 0.870, a sensitivity of 0.755 and a specificity of 0.922.
The accuracy results were not statistically different from those obtained with the best classifier
at T1 and T2.
The main conclusion of this study is that it is possible to predict the risk of death in the
acute phase of septic and cardiogenic shock with quite acceptable results by taking into consid-
eration the attributes routinely measured through echocardiography in the ICU. Use of this
data for assessing the prognosis of patients is considered valuable for the clinical management
of patients with shock in the ICU at ICU admission or during the first day of evolution.
The results presented here open up a new line of research for the study of the pathophysiol-
ogy of shock when combined with other data related to organ dysfunction beyond the com-
monly used scales such as the SOFA score. In the next step of this research, we plan to add
other types of data that are related to the patient’s response to shock and assess to what extend
the expanded models may yield improved results. This new layer of data will include transcrip-
tomics, proteomics and metabolomics features as detailed in the scope of the ShockOmics
European project.
Supporting information
S1 Appendix. Complementary material for the FS and causal discovery experiments. The
resulting features from applying multiple FS techniques to the three available datasets, their
stability scores, additional CBNs and a full list of ShockOmics attributes.
(PDF)
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